Schelosky L - Search Results

1

Iodine-123-iodo-lisuride SPECT in Parkinson's disease.

Cordes M, Hierholzer J, Schelosky L, Schrag A, Richter WS, Eichstädt H, Schulze PE, Poewe W, Felix R. Cordes M, et al. Among authors: schelosky l. J Nucl Med. 1996 Jan;37(1):22-5. J Nucl Med. 1996. PMID: 8543995 Free article.

2

[The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients].

Hierholzer J, Cordes M, Schelosky L, Barzen G, Poewe W, Henkes H, Keske U, Horowski R, Felix R. Hierholzer J, et al. Among authors: schelosky l. Rofo. 1992 Oct;157(4):390-8. doi: 10.1055/s-2008-1033028. Rofo. 1992. PMID: 1391843 German.

3

[Brain SPECT with 123I-lisuride in patients with Parkinson's disease and controls].

Hierholzer J, Cordes M, Schelosky L, Richter W, Schrag A, Poewe W, Schulze PE, Semmler W, Eichstädt H, Felix R. Hierholzer J, et al. Among authors: schelosky l. Nuklearmedizin. 1995 Aug;34(4):141-5. Nuklearmedizin. 1995. PMID: 7675643 German.

4

Dystonia in ataxia telangiectasia: report of a case with putaminal lesions and decreased striatal [123I]iodobenzamide binding.

Koepp M, Schelosky L, Cordes I, Cordes M, Poewe W. Koepp M, et al. Among authors: schelosky l. Mov Disord. 1994 Jul;9(4):455-9. doi: 10.1002/mds.870090414. Mov Disord. 1994. PMID: 7969215

5

Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis.

Hierholzer J, Cordes M, Schelosky L, Richter W, Keske U, Venz S, Semmler W, Poewe W, Felix R. Hierholzer J, et al. Among authors: schelosky l. J Nucl Med. 1994 Dec;35(12):1921-7. J Nucl Med. 1994. PMID: 7989970 Free article. Clinical Trial.

6

Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT.

Schelosky L, Hierholzer J, Wissel J, Cordes M, Poewe W. Schelosky L, et al. Mov Disord. 1993 Oct;8(4):453-8. doi: 10.1002/mds.870080406. Mov Disord. 1993. PMID: 8232354

7

[The differential diagnosis of Parkinson diseases--123I-IBZM-SPECT vs. the apomorphine test].

Hierholzer J, Cordes M, Schelosky L, Sander B, Böck JC, David I, Horowski R, Poewe W. Hierholzer J, et al. Among authors: schelosky l. Rofo. 1993 Jul;159(1):86-90. doi: 10.1055/s-2008-1032726. Rofo. 1993. PMID: 8334264 German.

8

IBZM-SPECT imaging in Parkinson's disease. Quantification of binding ratios from sequential SPECT measurements in patients and controls.

Cordes M, Hierholzer J, Schelosky L, Poewe W, Cordes I, Horowski R, Eichstaedt H, Schmidt D, Felix R. Cordes M, et al. Among authors: schelosky l. Adv Neurol. 1993;60:525-8. Adv Neurol. 1993. PMID: 8420183 No abstract available.

9

[Cerebral SPECT with iodine-123 IBZM in patients with extrapyramidal system disorders: the evaluation of its sensitivity in therapy with dopaminergic drugs].

Hierholzer J, Castelli L, Cordes M, Schelosky L, Poewe W, Felix R. Hierholzer J, et al. Among authors: schelosky l. Radiol Med. 1996 Mar;91(3):207-10. Radiol Med. 1996. PMID: 8628932 Italian.

10

Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.

Hierholzer J, Cordes M, Venz S, Schelosky L, Harisch C, Richter W, Keske U, Hosten N, Mäurer J, Poewe W, Felix R. Hierholzer J, et al. Among authors: schelosky l. J Nucl Med. 1998 Jun;39(6):954-60. J Nucl Med. 1998. PMID: 9627325 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters